PubMed

Treating hypertension in diabetic nephropathy.

Tomlinson JW, Owen KR, Close CF.

Diabetes Care. 2003 Jun;26(6):1802-5.PMID: 12766113 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

Lewis EJ, Lewis JB.

Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.PMID: 14586737 [PubMed - indexed for MEDLINE]Related articles

Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.

Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.

Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.PMID: 15835375 [PubMed - indexed for MEDLINE]Related articles

[Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy]

Lou LM, Gimeno JA, Gómez Sánchez R, Labrador T, Beguer P, Lou MT, Boned B, Aguilar E.

Nefrologia. 2002;22(2):179-89. Spanish. PMID: 12085419 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.

Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ.

Am J Kidney Dis. 1999 Nov;34(5):809-17.PMID: 10561135 [PubMed - indexed for MEDLINE]Related articles

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Estacio RO, Jeffers BW, Gifford N, Schrier RW.

Diabetes Care. 2000 Apr;23 Suppl 2:B54-64.PMID: 10860192 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease.

Palmer AJ, Annemans L, Roze S, Lamotte M, Lapuerta P, Chen R, Gabriel S, Carita P, Rodby RA, de Zeeuw D, Parving HH.

Diabetes Care. 2004 Aug;27(8):1897-903.PMID: 15277414 [PubMed - indexed for MEDLINE]Related articlesFree article

New treatment guidelines for a patient with diabetes and hypertension.

Mogensen CE.

J Hypertens Suppl. 2003 Mar;21(1):S25-30. Review.PMID: 12769164 [PubMed - indexed for MEDLINE]Related articles

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.

Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ.

J Am Soc Nephrol. 2005 Oct;16(10):3027-37. Epub 2005 Aug 24.PMID: 16120823 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluating the treatment of hypertension in diabetes mellitus: a need for better control?

Sequeira RP, Al Khaja KA, Damanhori AH.

J Eval Clin Pract. 2004 Feb;10(1):107-16.PMID: 14731158 [PubMed - indexed for MEDLINE]Related articles

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

Ruilope LM, Usan L, Segura J, Bakris GL.

J Hypertens. 2004 Jan;22(1):217-22.PMID: 15106814 [PubMed - indexed for MEDLINE]Related articles

Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Thomas MC, Atkins RC.

Drugs. 2006;66(17):2213-34. Review.PMID: 17137404 [PubMed - indexed for MEDLINE]Related articles

Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.

Andersen S, Jacobsen P, Tarnow L, Rossing P, Juhl TR, Parving HH.

Nephrol Dial Transplant. 2003 Feb;18(2):293-7.PMID: 12543883 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM; RENAAL Study Group.

Arch Intern Med. 2003 Jul 14;163(13):1555-65.PMID: 12860578 [PubMed - indexed for MEDLINE]Related articlesFree article

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J.

Am J Kidney Dis. 2000 Sep;36(3):646-61. Review.PMID: 10977801 [PubMed - indexed for MEDLINE]Related articles

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.PMID: 14871059 [PubMed - indexed for MEDLINE]Related articles

Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.

Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M.

Arch Intern Med. 1992 Jun;152(6):1225-9.PMID: 1599351 [PubMed - indexed for MEDLINE]Related articles

Optimal dose of losartan for renoprotection in diabetic nephropathy.

Andersen S, Rossing P, Juhl TR, Deinum J, Parving HH.

Nephrol Dial Transplant. 2002 Aug;17(8):1413-8.PMID: 12147788 [PubMed - indexed for MEDLINE]Related articlesFree article

Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: focus on hypertension and proteinuria.

Lee GS.

Ann Acad Med Singapore. 2005 Jan;34(1):24-30. Review.PMID: 15726216 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypertension and antihypertensive treatment of diabetic nephropathy.

Ritz E, Dikow R.

Nat Clin Pract Nephrol. 2006 Oct;2(10):562-7. Review.PMID: 17003835 [PubMed - indexed for MEDLINE]Related articles